Related Experiment Videos
Phenotype recognition. Clinicians' contributions to molecular genetics.
1Department of Medicine, University of New Mexico School of Medicine, Albuquerque.
The Western Journal of Medicine
|May 11, 1992
Summary
Genetic insights into inherited kidney diseases like medullary cystic disease, Alport syndrome, and autosomal dominant polycystic kidney disease are advancing. Ethical considerations for genetic testing in these renal disorders are crucial as molecular genetics progresses.
Area of Science:
- Nephrology
- Medical Genetics
- Bioethics
Background:
- Medullary cystic kidney disease, Alport syndrome, and autosomal dominant polycystic kidney disease are inherited renal disorders.
- Clinical observation has significantly advanced understanding of their genetic underpinnings.
Purpose of the Study:
- To explore the clinical aspects of these inherited renal disorders.
- To examine the intersection of molecular genetics and clinical presentation.
- To address ethical considerations surrounding genetic testing for these conditions.
Main Methods:
- Review of clinical observations of inherited renal disorders.
- Analysis of advancements in molecular genetics.
- Discussion of ethical implications of gene identification and diagnostic application.
Main Results:
- Established relationships between clinical features and genetic bases of studied renal diseases.
- Highlighted the rapid progress in molecular genetics.
- Identified key ethical issues requiring attention.
Conclusions:
- Understanding the genetic basis of inherited renal disorders is crucial.
- Molecular genetics offers powerful diagnostic potential.
- Proactive ethical deliberation is necessary before widespread application of genetic testing in nephrology.